Skip to main content
. 2022 Jul 22;10:941077. doi: 10.3389/fbioe.2022.941077

FIGURE 11.

FIGURE 11

Targeting ability of BM2-modified nanoparticles in vivo. (A) Fluorescence images of a BCG-infected rat at 3, 9, 24, 48, and 72 h post injection of DiR-labelled nanoparticles. (B) Quantitative fluorescence intensity (n = 3) of abscess tissue at different time points. (C) Biodistribution of DiR-labeled nanoparticles in major organs extracted from rats at 72 h post injection. (D) Quantitative analysis of fluorescence intensity (n = 3) in major organs. (E) CLSM images of Frozen section of abscess tissues at 24 h post-injection of DiR-loaded nanoparticles. The scale bar is 50 μm. Reproduced with permission from Li et al. (2021). Copyright © 2021 the authors.